Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

Meiogenix SAS

Meiogenix is a pioneer in chromosome editing, developing broadly applicable gene and chromosome editing capabilities that restore essential biodiversity to agriculture enabling unity between natural ecosystems and our food production. Meiogenix has collaborations with Cornell and Bayer to help develop crops that improve our food supply while caring for our environment. *


Period Start 2010-09-28 established
  Predecessor INRA (Institut National de la Recherche Agronomique) (FR)
Products Industry SpiX plant breeding technology
Persons Person Mathis, Luc (Meiogenix 202112 CEO before Global Bioenergies + Calyxt + Cellectis Plant Sciences)
  Person 2 Bastianelli, Giacomo (Meiogenix 201604 CEO + Co-Founder)
Region Region Paris
  Country France
  Street 38 rue Servan
Cedex 11
  City 75011 Paris
    Address record changed: 2022-03-09
Basic data Employees n. a.
    * Document for »About Section«: Meiogenix SAS. (12/14/21). "Press Release: Meiogenix Announces $13 Million Series A Financing Round Led by Sofinnova Partners". Paris.
Record changed: 2024-03-30


Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x200px

More documents for Meiogenix SAS

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group World of Partnering Opportunities 650x300px

» top